Induction of metaphase arrest in cleaving Xenopus embryos by the protein kinase p90(Rsk)

Science

Volumn 286, Issue 5443, 1999, Pages 1365-1367

  Gross, Stefan D ^a   Schwab, Markus S ^a   Lewellyn, Andrea L ^a   Maller, James L ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSTATIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE;

ARTICLE; BLASTOMERE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MEIOSIS; METAPHASE; NONHUMAN; OOCYTE CLEAVAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOPUS;

ANIMALS; BLASTOMERES; ENZYME ACTIVATION; MAP KINASE SIGNALING SYSTEM; MEIOSIS; METAPHASE; MITOGEN-ACTIVATED PROTEIN KINASES; MITOTIC SPINDLE APPARATUS; OOCYTES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MOS; RECOMBINANT PROTEINS; RIBOSOMAL PROTEIN S6 KINASES; RNA, MESSENGER; XENOPUS;

EID: 0032698220     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.286.5443.1365     Document Type: Article

References (29)

1. Y. Masui and C. L. Markert, J. Exp. Zool. 177, 129 (1971).
2. N. Sagata et al., Nature 342, 512 (1989); N. Yew et al., Nature 355, 649 (1992).
3. N. Sagata et al., Nature 342, 512 (1989); N. Yew et al., Nature 355, 649 (1992).
4. L. M. Roy et al., Oncogene 12, 2203 (1996).
5. O. Haccard et al., Science 262, 1262 (1993).
6. T. W. Sturgill et al., Nature 334, 715 (1988); J. R. Grove et al., Biochemistry 32, 7727 (1993).
7. T. W. Sturgill et al., Nature 334, 715 (1988); J. R. Grove et al., Biochemistry 32, 7727 (1993).
8. E. Erikson and J. L. Maller, J. Biol. Chem. 264, 13711 (1989); R. S. Hartley et al., Dev. Biol. 163, 521 (1994).
9. E. Erikson and J. L. Maller, J. Biol. Chem. 264, 13711 (1989); R. S. Hartley et al., Dev. Biol. 163, 521 (1994).
10. S. Jones et al., Proc. Natl. Acad. Sci. U.S.A. 85, 3377 (1988); D. A. Alcorta et al., Mol. Cell. Biol. 9, 3850 (1989).
11. S. Jones et al., Proc. Natl. Acad. Sci. U.S.A. 85, 3377 (1988); D. A. Alcorta et al., Mol. Cell. Biol. 9, 3850 (1989).
12. D. E. Moller et al., Am. J. Physiol. 266, 351 (1994); Y. Zhao et al., Mol. Cell. Biol. 15, 4353 (1995).
13. D. E. Moller et al., Am. J. Physiol. 266, 351 (1994); Y. Zhao et al., Mol. Cell. Biol. 15, 4353 (1995).
14. K. N. Dalby et al., J. Biol. Chem. 273, 1496 (1998).
15. T. L. Fisher and J. Blenis, Mol. Cell. Biol. 16, 1212 (1996); C. Bjørbaek et al., J. Biol. Chem. 270, 18848 (1995).
16. T. L. Fisher and J. Blenis, Mol. Cell. Biol. 16, 1212 (1996); C. Bjørbaek et al., J. Biol. Chem. 270, 18848 (1995).
17. S. J. Mansour et al., Science 265, 966 (1994).
18. Rsk (Rsk). Primers 1 and 4 and 2 and 4 were used to create constructs ΔCT Rsk and CA Rsk, respectively. Polymerase chain reaction products were subcloned into pOTV-FLAC-LIC with a ligation-independent cloning method (Novagen, Madison, WI). With the T7 promoter, this vector directs the synthesis of mRNA coding for a FLAG epitope fusion protein of the inserted gene. Messenger RNA was synthesized for each of the constructs with the T7 message machine kit (Ambion, Austin, TX).
19. 32P]ATP, and 250 μM S6 peptide (Upstate Biotechnology, Waltham, MA). Where indicated in Fig. 2, assays also contained 10 units of MAPK (New England Biolabs, Beverly, MA) or 2.5 ng of activated PDK-1 (Upstate Biotechnology). Reactions were incubated at 30°C for 60 min and quenched by the addition of EDTA to 60 mM. The beads were removed by centrifugation at 16,000g, and 10 μl of the supernatant were spotted onto p81 paper in duplicate, washed, dried, and counted by the Cerenkov method. Protein immunoblots were performed essentially as described elsewhere (3, 4).
20. N. Pullen et al., Science 279, 707 (1998); D. R. Alessi et al. Curr. Biol. 8, 69 (1998).
21. N. Pullen et al., Science 279, 707 (1998); D. R. Alessi et al. Curr. Biol. 8, 69 (1998).
22. Embryos were fertilized in vitro as previously described (4). Blastomeres of two-cell embryos were injected with 30 nl of mRNA (12.5 to 25 ng) encoding β-GaL, Mos, Rsk, ΔCT Rsk, or CA Rsk and then monitored with a dissecting microscope.
23. Confocal methods were performed essentially as described by Y.-W. Qian et al. Mol. Cell. Biol. 18, 4262 (1998).
24. D. L. Card, Dev. Biol. 151, 516 (1992).
25. K. Fukasawa and G. F. Vande Woude, Proc. Natl. Acad. Sci. U.S.A. 92, 3430 (1995).
26. W. T. Matten et al., Dev. Biol. 179, 485 (1996).
27. R. R. Bhatt and J. E. Ferrell, Science 286, 1362 (1999).
28. xe antibody (Santa Cruz Biotechnology, Santa Cruz, CA) and antibody to cydin B2 were used as previously described (3).
29. Rsk (9) and E. Erikson for a critical reading of the manuscript. Supported by grant DK28353 from NIH. S.D.G. and M.S.S. are Associates and J.LM. is an Investigator of the Howard Hughes Medical Institute.